Complete Story


MAT Training: Methadone and buprenorphine on March 11

clinical impact of drug interactions

APA MAT Training Logo

PCSS-MAT is a national training and mentoring project developed in response to the prescription opioid misuse epidemic and the availability of newer pharmacotherapies to address opioid dependence.

Methadone and Buprenorphine: Clinical Impact of Drug Interactions

Elinore McCance-Katz, MD, PhD

Chief Medical Officer

Substance Abuse and Mental Health Services Administration

Tuesday, March 11, 2014

Noon – 1 p.m. Eastern

Drug-drug interactions between opioid medications used to treat opioid use disorder, such as methadone and buprenorphine, and medications for treating co-occurring physical or mental health conditions can be a source of morbidity and mortality.

This presentation will briefly review the epidemiologic data on drug-drug interactions that include methadone or buprenorphine and discuss the physiological basis for such interactions including pharmacokinetic and/or pharmacodynamics interactions. It will also review drug-drug interactions and clinical consequences using a series of case studies that address questions related to issues of drug interactions in practice.

The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Psychiatric Association designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Register Now Button - Purple

The PCSS-MAT is a collaboration of: American Academy of Addiction Psychiatry (lead), American Psychiatric Association, American Osteopathic Academy of Addiction Medicine, and the American Society of Addiction Medicine. Funding for this initiative was made possible (in part) by Physicians' Clinical Support System for Medication Assisted Treatment (1U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Printer-Friendly Version